Vas Narasimhan, Novartis CEO (Akio Kon/Bloomberg via Getty Images)
Novartis execs highlight progress of slimmer pipeline after Sandoz spinoff
Novartis executives on Tuesday crystallized their ongoing R&D strategy shift in the wake of the Sandoz spinoff, with CEO Vas Narasimhan and others outlining how …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.